Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

We investigate infectious diseases in primary care to find out how we can identify patients with serious infection in primary care, and more effective ways of diagnosing and treating patients with common infections.

We are working on a number of studies looking at how to diagnose and treat various common infectious diseases in children and adults in primary care.

Our work is important because it will help primary care clinicians to decide how best to identify which patients presenting with common symptoms such as coughs and colds are most likely to develop serious complications. This will help GPs know which patients are most likely to benefit from antibiotics. This can help to reduce unnecessary prescribing of antibiotics that is adding to resistance to antibiotics in many countries. We are running a number of very large studies to help answer these questions, which involve recruiting thousands of patients from across the UK.

We are also examining novel ways of diagnosing other infections such as whooping cough in people presenting with cough, as this may be an important cause of persistent coughing even in children and adults who have been vaccinated against this infection. We are also examining how many children with a persistent cough may have whooping cough; and trialling a drug which may be an effective treatment for persistent coughs.

In parallel, we are running trials to investigate treatments other than antibiotics for patients presenting with common cough and cold symptoms. This may give GPs and patients treatment options other than antibiotics to help relieve symptoms for these common illnesses.

Many of our researchers are major contributors to the NIHR Diagnostic Evidence Co-operative Oxford which is hosted by this department. 

Our team

Latest news

Flu antiviral has bigger benefits for sicker, older patients

A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir (Tamiflu®), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.

Selected publications

Our blogs:

Antibiotics: even low use in children can have a negative impact on health – new research

Taking any antibiotic makes developing antibiotic resistance more likely. Dr Oliver van Hecke, Clinical Lecturer and GP, writes about his latest study showing that even relatively low antibiotic use has potential health implications.

Attending the House of Commons as panel expert

NIHR Academic Clinical Lecturer, Dr Oliver van Hecke, describes his recent experience as a panel member on a All-Party Parliamentary Group event on antimicrobial resistance.

Meet a student - Ali Albasri

DPhil student Ali Albasri meets CLAHRC Communications Officer Gavin Hubbard for PPI Pulse Magazine.


Whooping Cough